Evidence map›Paper›PMID 32752248›Full record

ArticleJournal of functional biomaterials2020

Novel CaF

Heba Mitwalli, Abdulrahman A Balhaddad, Rashed AlSahafi, Thomas W Oates, Mary Anne S Melo, Hockin H K Xu, Michael D Weir

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Novel antibacterial low-shrinkage-stress resin-based cement.Dental materials : official publication of the Academy of Dental Materials · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Heba MitwalliProgram in Dental Biomedical Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, USA.
Abdulrahman A BalhaddadProgram in Dental Biomedical Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, USA.ORCID 0000-0001-6678-7940
Rashed AlSahafiProgram in Dental Biomedical Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, USA.
Thomas W OatesDepartment of Advanced Oral Sciences and Therapeutics, School of Dentistry, University of Maryland, Baltimore, MD 21201, USA.
Mary Anne S MeloDepartment of Advanced Oral Sciences and Therapeutics, School of Dentistry, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0002-0007-2966
Hockin H K XuDepartment of Advanced Oral Sciences and Therapeutics, School of Dentistry, University of Maryland, Baltimore, MD 21201, USA.
Michael D WeirDepartment of Advanced Oral Sciences and Therapeutics, School of Dentistry, University of Maryland, Baltimore, MD 21201, USA.
University of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The objective of this study was to develop a novel dental nanocomposite containing dimethylaminohexadecyl methacrylate (DMAHDM), 2-methacryloyloxyethyl phosphorylcholine (MPC), and nanoparticles of calcium fluoride (nCaF

Indexed as

antibacterialcalcium fluoride nanoparticlesdental nanocompositeoral biofilmprotein repellentremineralization

Identifiers

PMID32752248
PMCPMC7564802
OpenAlexW3046413908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.